Keybanc analyst Justin Patterson initiates coverage on DoubleVerify Hldgs (NYSE:DV) with a Sector Weight rating.
Biohaven And Pfizer Receive Positive CHMP Opinion For Migraine Treatment
Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) and Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive